Replies to post #117365 on Regen BioPharma Inc (RGBP)

[Valuator2]

With an existing IP portfolio and patent apps for 2 inventions to expand Car-T to solid tumors in a company with such a low MC and relatively low $5 million plan to prove it out, if the science is good, I tend to think that's a possibility. One question that wasn't asked in the CC was whether he was buying common shares now. Somebody is. JMHO.